Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Liability of VLN Menthol Cigarettes
NCT03559725Phase 1Completed
- Sponsor
- 22nd Century Group
- Start
- May 2018
- Primary completion
- Oct 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (3 arms), sponsored by 22nd Century Group. Primary endpoint: Maximum Urge to Smoke (Emax) at 3 days. Started May 2018; status: completed.
Beyond the preview
Go deeper on NCT03559725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03559725.